Literature DB >> 11455793

New antimalarial treatment for KwaZulu-Natal.

L Baker, K Barnes.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11455793

Source DB:  PubMed          Journal:  S Afr Med J


× No keyword cloud information.
  4 in total

1.  Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa.

Authors:  Karen I Barnes; David N Durrheim; Francesca Little; Amanda Jackson; Ushma Mehta; Elizabeth Allen; Sicelo S Dlamini; Joyce Tsoka; Barry Bredenkamp; D Jotham Mthembu; Nicholas J White; Brian L Sharp
Journal:  PLoS Med       Date:  2005-10-04       Impact factor: 11.069

2.  Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether.

Authors:  Colin J Sutherland; Rosalynn Ord; Sam Dunyo; Musa Jawara; Christopher J Drakeley; Neal Alexander; Rosalind Coleman; Margaret Pinder; Gijs Walraven; Geoffrey A T Targett
Journal:  PLoS Med       Date:  2005-04-26       Impact factor: 11.069

3.  Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018).

Authors:  Jaishree Raman; Frank M Kagoro; Aaron Mabuza; Gillian Malatje; Anthony Reid; John Frean; Karen I Barnes
Journal:  Malar J       Date:  2019-08-22       Impact factor: 2.979

4.  From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.

Authors:  Naawa Sipilanyambe; Jonathon L Simon; Pascalina Chanda; Peter Olumese; Robert W Snow; Davidson H Hamer
Journal:  Malar J       Date:  2008-01-29       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.